SOL-1 is the first registrational trial for AXPAXLI™ in wet AMD. Topline clinical data from SOL-1 expected in Q4 2025. Active clinical trial sites enrolling patients directly in ...
PG&E Corporation (NYSE: PCG) ("PG&E" or the "Company") announced today the launch of concurrent underwritten public offerings of (i) $1,200 million of shares of common stock, no par value ("Common ...
Auberge Resorts Collection, the award-winning portfolio of one-of-a-kind luxury hotels, resorts and residences, has been selected to manage Moncayo, Auberge Resorts Collection, a new beachfront resort ...